Skip to Content

NAFTIDROFURYL CAPSULES BP 100MG

Active substance(s): NAFTIDROFURYL OXALATE

View full screen / Print PDF » Download PDF ⇩
Transcript
Naftidrofuryl 100mg capsules
Read all of this leaflet carefully
before you start taking this
medicine because it contains
important information for you.
• Keep this leaflet. You may need to
read it again.
• If you have any further questions, ask
your doctor, pharmacist or nurse.
• This medicine has been prescribed for
you only. Do not pass it on to others.
It may harm them, even if their signs
of illness are the same as yours.
• If you get any side effects, talk to your
doctor, pharmacist or nurse. This
includes any possible side effects not
listed in this leaflet. See section 4.

What is in this leaflet
1 What Naftidrofuryl capsules are
and what they are used for
2 What you need to know before you
take Naftidrofuryl capsules
3 How to take Naftidrofuryl capsules
4 Possible side effects
5 How to store Naftidrofuryl capsules
6 Contents of the pack and other
information
1 What Naftidrofuryl capsules are

and what they are used for

Naftidrofuryl capsules belong to a group of
medicines called vasodilators. This medicine
helps improve blood flow in the body.
Naftidrofuryl capsules are used to treat:
• poor blood supply, causing:
- cramps, usually in the calf and leg muscles,
during walking or exercise or in the legs at
night.
- pains whilst resting, usually in the feet.
- gangrene.
- ulcers on the skin.
- painful, numb, cold or blue fingers
(Raynaud’s syndrome).
- blue hands and feet.
- disease of the arteries caused by diabetes.

2 What you need to know before you

take Naftidrofuryl capsules

Do not take Naftidrofuryl capsules if you:

• are allergic to naftidrofuryl oxalate or any of
the other ingredients of this medicine (listed
in section 6).
• have a history of excessive amounts of oxalic
acid (oxalates) in the urine or recurrent
calcium stones such as kidney stones.

Warnings and Precautions

Talk to your doctor, pharmacist or nurse before
taking Naftidrofuryl capsules if you:
• have kidney or liver disorders.

Other medicines and Naftidrofuryl
capsules

Tell your doctor or pharmacist if you are taking
or have recently taken or might take any other
medicines.

Pregnancy and breast-feeding

If you are pregnant or breast-feeding, think
you may become pregnant or are planning to
have a baby, ask your doctor or pharmacist for
advice before taking this medicine.

Driving and using machines

Naftidrofuryl capsules may cause dizziness.
Make sure you are not affected before driving
or operating machinery.

3 How to take Naftidrofuryl capsules

Always take this medicine exactly as your doctor
or pharmacist has told you. Check with your
doctor or pharmacist if you are not sure.

Doses

Adults and Elderly:
Poor blood supply: The recommended dose is
one or two capsules three times a day for at least
three months.
Patients with kidney disorders may be prescribed
a lower dose.

Continued top of next column

Continued over page

148x210 Leaflet Reel Fed Profile (BST)

Naftidrofuryl 100mg capsule leaflet - UK

colours/plates:
1. Black

item no:
print proof no:

AAAI2574
3

origination date: 08.09.15
approved for print/date

originated by:

DR

revision date:

21.10.15

dimensions:

148 x 210

pharmacode:
min pt size:

JDE No.:

3.

Dimensions: 148x210 (Reel Fed)
Component: Leaflet for Blisters

5.
6.

Technical Approval

revised by:

DR

date sent:

supplier:

UK

technically app. date: N/A

N/A

50870071

2.
4.

8.5pt

Naftidrofuryl Capsules
100mg x 84’s (UK)

Non Printing Colours
1. Profile
2.
3.

Pharmacode: 1747
Date Sent:
28/08/15
Technologist: R.Wrey
Technically Approved
Actavis BST - Packing Technical
BSTCutterGuideReq@actavis.com

Children and adolescents
Not recommended.
Swallow the capsules with a glass of water, with or
after food, do not chew them. It is important to drink
plenty of water while you are taking this medicine.

Reporting of side effects
If you get any side effects, talk to your doctor,
pharmacist or nurse. This includes any possible side
effects not listed in this leaflet. You can also report side
effects directly via the Yellow Card Scheme at: www.
mhra.gov.uk/yellowcard

If you take more Naftidrofuryl capsules than
you should

By reporting side effects you can help provide more
information on the safety of this medicine.

If you (or someone else) swallow a lot of capsules
at the same time, or you think a child may have
swallowed any, contact your nearest hospital casualty
department or tell your doctor immediately. Signs of
an overdose include changes in heart rhythm and fits.

If you forget to take Naftidrofuryl capsules

Do not take a double dose to make up for a forgotten
dose. If you forget to take a dose take it as soon as you
remember it and then take the next dose at the right
time.

If you stop taking Naftidrofuryl capsules

If you have any further questions on the use of this
medicine, ask your doctor, pharmacist or nurse. Do not
stop taking Naftidrofuryl capsules unless your doctor
tells you to, even if you feel better.

4 Possible side effects

Like all medicines, this medicine can cause side effects,
although not everybody gets them.
If you experience any of the following side effects with
Naftidrofuryl capsules, STOP taking the capsules,
contact your doctor immediately and consider
attending hospital casualty: A severe allergic
reaction, such as itching, swelling of the face, lips,
tongue, mouth, or throat, which may cause shortness
of breath, wheezing, or difficulty breathing.
Tell your doctor if you notice any of the following side
effects or notice any other effects not listed:
Uncommon: may affect up to 1 in 100 people
Diarrhoea, feeling or being sick, stomach pain, skin
rash
Rare: may affect up to 1 in 1,000 people
Liver damage
Very rare: may affect up to 1 in 10,000 people
Kidney stones

5 How to store Naftidrofuryl capsules

Keep out of the sight and reach of children.
Store below 25°C in a dry place. Protect from light.
Do not use this medicine after the expiry date stated
on the carton after EXP. The expiry date refers to the
last day of that month.
Medicines should not be disposed of via wastewater
or household waste. Ask your pharmacist how to
dispose of medicines no longer use. These measures
will help protect the environment.

6 Contents of the pack and other

information

What Naftidrofuryl capsules contain

• The active substance (the ingredient that makes the
capsule work) is naftidrofuryl oxalate. Each capsule
contains 100mg of the active ingredient.
• The capsule contains: maize starch, microcrystalline
cellulose (E460), sodium starch glycollate, colloidal
silica, stearic acid, magnesium stearate.
• The capsule shell contains: erythrosine (E127),
titanium dioxide (E171), gelatin.
• The printing ink contains: Shellac (E904),
propylene glycol (E1520), iron oxide black
(E172) and potassium hydroxide (E525).

What Naftidrofuryl capsules look like
and contents of the pack
Naftidrofuryl are pink, hard gelatin capsules.
Pack sizes are 84 capsules.
Marketing Authorisation Holder and
Manufacturer:
Actavis, Barnstaple, EX32 8NS, UK.
Date of revision:
October 2015

Not known: frequency cannot be estimated from
the available data
Hepatitis (inflammation of the liver), liver failure,
dizziness, headache, agitation and sleep disturbances,
inflammation in the throat when capsule not taken
with sufficient amount of liquid.
Continued top of next column
50870071 AAAI2574

Actavis, Barnstaple, EX32 8NS, UK

148x210 Leaflet Reel Fed Profile (BST)

Naftidrofuryl 100mg capsule leaflet - UK

colours/plates:
1. Black

item no:
print proof no:

AAAI2574
3

origination date: 08.09.15
approved for print/date

originated by:

DR

revision date:

21.10.15

dimensions:

148 x 210

pharmacode:
min pt size:

JDE No.:

3.

Dimensions: 148x210 (Reel Fed)
Component: Leaflet for Blisters

5.
6.

Technical Approval

revised by:

DR

date sent:

supplier:

UK

technically app. date: N/A

N/A

50870071

2.
4.

8.5pt

Naftidrofuryl Capsules
100mg x 84’s (UK)

Non Printing Colours
1. Profile
2.
3.

Pharmacode: 1747
Date Sent:
28/08/15
Technologist: R.Wrey
Technically Approved
Actavis BST - Packing Technical
BSTCutterGuideReq@actavis.com

Expand view ⇕

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide